Leptomycin B ameliorates vasogenic edema formation induced by status epilepticus via inhibiting p38 MAPK/VEGF pathway
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Duk-Soo | - |
dc.contributor.author | Min, Su-Ji | - |
dc.contributor.author | Kim, Min-Ju | - |
dc.contributor.author | Kim, Ji-Eun | - |
dc.contributor.author | Kang, Tae-Cheon | - |
dc.date.accessioned | 2021-08-11T16:44:30Z | - |
dc.date.available | 2021-08-11T16:44:30Z | - |
dc.date.issued | 2016-11-15 | - |
dc.identifier.issn | 0006-8993 | - |
dc.identifier.issn | 1872-6240 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/8600 | - |
dc.description.abstract | The blood-brain barrier (BBB) disruption during brain insults leads to vasogenic edema as one of the primary steps in the epileptogenic process. However, the signaling pathway concerning vasogenic edema formation has not been clarified. In the present study, status epilepticus (SE) resulted in vascular endothelial growth factor (VEGF) over-expression accompanied by loss of BBB integrity in the rat piriform cortex. Leptomycin B (LMB, an inhibitor of chromosome region maintenance 1) attenuated SE-induced vasogenic edema formation. This anti-edema effect of LMB was relevant to inhibitions of VEGF over expression as well as p38 mitogen-activated protein kinase (MAPK) phosphorylation. Furthermore, 513202190 (a p38 MAPK inhibitor) ameliorated vasogenic edema and VEGF over-expression induced by SE. These findings indicate that p38 MAPK/VEGF signaling pathway may be involved in BBB disruption following SE. Thus, we suggest that p38 MAPK/VEGF axis may be one of therapeutic targets for vasogenic edema in various neurological diseases. (C) 2016 Elsevier B.V. All rights reserved. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Elsevier BV | - |
dc.title | Leptomycin B ameliorates vasogenic edema formation induced by status epilepticus via inhibiting p38 MAPK/VEGF pathway | - |
dc.type | Article | - |
dc.publisher.location | 네델란드 | - |
dc.identifier.doi | 10.1016/j.brainres.2016.09.023 | - |
dc.identifier.scopusid | 2-s2.0-84991017384 | - |
dc.identifier.wosid | 000387527100004 | - |
dc.identifier.bibliographicCitation | Brain Research, v.1651, pp 27 - 35 | - |
dc.citation.title | Brain Research | - |
dc.citation.volume | 1651 | - |
dc.citation.startPage | 27 | - |
dc.citation.endPage | 35 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.subject.keywordPlus | ENDOTHELIAL GROWTH-FACTOR | - |
dc.subject.keywordPlus | BRAIN-BARRIER PERMEABILITY | - |
dc.subject.keywordPlus | NECROTIC NEURONAL DEATH | - |
dc.subject.keywordPlus | CHROMATIN PROTEIN HMGB1 | - |
dc.subject.keywordPlus | STABILITY FACTOR HUR | - |
dc.subject.keywordPlus | MOBILITY GROUP BOX-1 | - |
dc.subject.keywordPlus | FACTOR-A | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | RECEPTOR | - |
dc.subject.keywordPlus | SEIZURE | - |
dc.subject.keywordAuthor | Epilepsy | - |
dc.subject.keywordAuthor | Seizure | - |
dc.subject.keywordAuthor | Leptomycin B | - |
dc.subject.keywordAuthor | P38 MAPK | - |
dc.subject.keywordAuthor | VEGF | - |
dc.subject.keywordAuthor | Piriform cortex | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.